AxoGen (AXGN) News Today $20.01 +0.58 (+2.99%) Closing price 02/28/2025 04:00 PM EasternExtended Trading$21.00 +0.99 (+4.95%) As of 09:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Leerink Partnrs Predicts AxoGen FY2029 EarningsMarch 2 at 3:27 AM | americanbankingnews.comCantor Fitzgerald Decreases Earnings Estimates for AxoGenMarch 2 at 2:37 AM | americanbankingnews.comLeerink Partnrs Forecasts AxoGen FY2029 EarningsAxoGen, Inc. (NASDAQ:AXGN - Free Report) - Equities researchers at Leerink Partnrs issued their FY2029 earnings per share (EPS) estimates for shares of AxoGen in a report issued on Tuesday, February 25th. Leerink Partnrs analyst M. Kratky expects that the medical equipment provider will earn $0.3March 1 at 9:24 AM | marketbeat.comFY2025 EPS Estimates for AxoGen Lowered by Cantor FitzgeraldAxoGen, Inc. (NASDAQ:AXGN - Free Report) - Equities research analysts at Cantor Fitzgerald reduced their FY2025 earnings per share estimates for shares of AxoGen in a report issued on Wednesday, February 26th. Cantor Fitzgerald analyst R. Osborn now forecasts that the medical equipment provider wMarch 1 at 8:30 AM | marketbeat.comAxoGen (NASDAQ:AXGN) Price Target Raised to $26.00 at Canaccord Genuity GroupCanaccord Genuity Group increased their price objective on shares of AxoGen from $22.00 to $26.00 and gave the company a "buy" rating in a report on Wednesday.February 27, 2025 | marketbeat.comAxoGen price target raised to $26 from $22 at CanaccordFebruary 26, 2025 | markets.businessinsider.comAxoGen price target raised to $26 from $20 at Citizens JMPFebruary 26, 2025 | markets.businessinsider.comAxogen Inc (AXGN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Market ...February 26, 2025 | finance.yahoo.comAxogen shares surge 11% on Q4 earnings beat, strong revenue growthFebruary 25, 2025 | za.investing.comAxogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial ResultsFebruary 25, 2025 | markets.businessinsider.comAxoGen price target raised to $25 from $18 at LeerinkFebruary 25, 2025 | markets.businessinsider.comAxogen, Inc. (AXGN) Q4 2024 Earnings Call TranscriptFebruary 25, 2025 | seekingalpha.comAxoGen (NASDAQ:AXGN) Shares Gap Down on Disappointing EarningsAxoGen (NASDAQ:AXGN) Shares Gap Down Following Weak EarningsFebruary 25, 2025 | marketbeat.comAxoGen (NASDAQ:AXGN) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPSAxoGen (NASDAQ:AXGN - Get Free Report) announced its quarterly earnings data on Tuesday. The medical equipment provider reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.03). AxoGen had a negative return on equity of 14.91% and a negative net margin of 7.91%.February 25, 2025 | marketbeat.comAxogen, Inc. To Host Analyst & Investor Day on March 4thFebruary 25, 2025 | globenewswire.comAxoGen (NASDAQ:AXGN) Sets New 1-Year High - What's Next?AxoGen (NASDAQ:AXGN) Sets New 1-Year High - Here's WhyFebruary 22, 2025 | marketbeat.comHussman Strategic Advisors Inc. Takes $519,000 Position in AxoGen, Inc. (NASDAQ:AXGN)Hussman Strategic Advisors Inc. acquired a new stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 31,500 shares of the medical equipment provider'sFebruary 22, 2025 | marketbeat.comAxoGen (AXGN) Expected to Announce Earnings on TuesdayAxoGen (NASDAQ:AXGN) will be releasing earnings before the market opens on Tuesday, February 25. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=236575)February 21, 2025 | marketbeat.comWe Might See A Profit From Axogen, Inc. (NASDAQ:AXGN) SoonFebruary 18, 2025 | uk.finance.yahoo.comAxoGen, Inc. (NASDAQ:AXGN) Short Interest Up 50.8% in JanuaryAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) was the target of a significant growth in short interest in January. As of January 31st, there was short interest totalling 1,870,000 shares, a growth of 50.8% from the January 15th total of 1,240,000 shares. Based on an average daily trading volume, of 416,600 shares, the days-to-cover ratio is currently 4.5 days.February 13, 2025 | marketbeat.comAxogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025February 11, 2025 | globenewswire.comAxoGen (NASDAQ:AXGN) Sets New 1-Year High - Here's What HappenedAxoGen (NASDAQ:AXGN) Reaches New 1-Year High - Here's WhyFebruary 6, 2025 | marketbeat.comCalamos Advisors LLC Acquires New Position in AxoGen, Inc. (NASDAQ:AXGN)Calamos Advisors LLC bought a new stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 31,725 shares of the medical equipment provider's stock, valued at approximately $523,000February 6, 2025 | marketbeat.comAxoGen price target raised to $22 from $18 at CanaccordFebruary 3, 2025 | markets.businessinsider.comAxoGen appoints Jesse Bishop as VP, regulatory affairsFebruary 3, 2025 | markets.businessinsider.comAxogen appoints new VP of Regulatory AffairsFebruary 3, 2025 | msn.comAxogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)February 3, 2025 | markets.businessinsider.comAxoGen (NASDAQ:AXGN) Given New $22.00 Price Target at Canaccord Genuity GroupCanaccord Genuity Group upped their price target on AxoGen from $18.00 to $22.00 and gave the company a "buy" rating in a research note on Monday.February 3, 2025 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Sees Significant Growth in Short InterestAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) saw a large growth in short interest in January. As of January 15th, there was short interest totalling 1,240,000 shares, a growth of 20.4% from the December 31st total of 1,030,000 shares. Based on an average daily trading volume, of 426,600 shares, the short-interest ratio is presently 2.9 days.February 1, 2025 | marketbeat.comCantor Fitzgerald Reduces Earnings Estimates for AxoGenAxoGen, Inc. (NASDAQ:AXGN - Free Report) - Investment analysts at Cantor Fitzgerald reduced their FY2024 EPS estimates for AxoGen in a research report issued to clients and investors on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn now anticipates that the medical equipment providerJanuary 23, 2025 | marketbeat.comAxoGen (NASDAQ:AXGN) Reaches New 1-Year High - Time to Buy?AxoGen (NASDAQ:AXGN) Sets New 52-Week High - Here's WhyJanuary 23, 2025 | marketbeat.comAxogen stock soars to 52-week high, touches $18.99January 21, 2025 | msn.comAxoGen, Inc. (NASDAQ:AXGN) Shares Sold by Assenagon Asset Management S.A.Assenagon Asset Management S.A. decreased its stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 37.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 826,536 shares of the medical equipment provider's stock after selling 48January 18, 2025 | marketbeat.comAxoGen (NASDAQ:AXGN) Sets New 52-Week High - Still a Buy?AxoGen (NASDAQ:AXGN) Hits New 1-Year High - Should You Buy?January 17, 2025 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Shares Bought by JPMorgan Chase & Co.JPMorgan Chase & Co. lifted its stake in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 2,912.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 549,000 shares of the medical equipment provider's stock after purchasingJanuary 15, 2025 | marketbeat.comBarclays PLC Raises Holdings in AxoGen, Inc. (NASDAQ:AXGN)Barclays PLC grew its stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 119.3% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 72,036 shares of the medical equipment provider's stock after buying an additional 39,182 shares during the quarter. Barclays PLC owJanuary 15, 2025 | marketbeat.comAxoGen (NASDAQ:AXGN) Hits New 1-Year High - Still a Buy?AxoGen (NASDAQ:AXGN) Reaches New 12-Month High - Here's What HappenedJanuary 11, 2025 | marketbeat.comAxogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)January 10, 2025 | globenewswire.comAxoGen (NASDAQ:AXGN) Trading Up 6.7% - Still a Buy?AxoGen (NASDAQ:AXGN) Trading 6.7% Higher - Should You Buy?January 10, 2025 | marketbeat.comAxogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024January 10, 2025 | markets.businessinsider.comAxogen: Well Placed To Capitalize Growth At Higher MultiplesJanuary 6, 2025 | seekingalpha.comAxoGen (NASDAQ:AXGN) Stock Price Down 4.8% - What's Next?AxoGen (NASDAQ:AXGN) Shares Down 4.8% - Should You Sell?January 3, 2025 | marketbeat.comShort Interest in AxoGen, Inc. (NASDAQ:AXGN) Decreases By 7.3%AxoGen, Inc. (NASDAQ:AXGN - Get Free Report) was the target of a large decrease in short interest during the month of December. As of December 15th, there was short interest totalling 1,010,000 shares, a decrease of 7.3% from the November 30th total of 1,090,000 shares. Based on an average trading volume of 356,700 shares, the short-interest ratio is currently 2.8 days.December 31, 2024 | marketbeat.comGeode Capital Management LLC Buys 31,612 Shares of AxoGen, Inc. (NASDAQ:AXGN)Geode Capital Management LLC lifted its stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 3.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,010,508 shares of the medical equipment provider'December 31, 2024 | marketbeat.comBarclays PLC Purchases 39,182 Shares of AxoGen, Inc. (NASDAQ:AXGN)Barclays PLC lifted its position in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 119.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 72,036 shares of the medical equipment provider's stockDecember 31, 2024 | marketbeat.comState Street Corp Purchases 95,051 Shares of AxoGen, Inc. (NASDAQ:AXGN)State Street Corp raised its holdings in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 11.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 896,674 shares of the medical equipment provider's stock afterDecember 26, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Stock Price Down 4.8% - Should You Sell?AxoGen (NASDAQ:AXGN) Shares Down 4.8% - Here's WhyDecember 24, 2024 | marketbeat.comAxoGen (NASDAQ:AXGN) Hits New 52-Week High - Still a Buy?AxoGen (NASDAQ:AXGN) Reaches New 12-Month High - Time to Buy?December 23, 2024 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Shares Sold by M&T Bank CorpM&T Bank Corp cut its holdings in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 50.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,682 shares of the medical equipment provider's stock after selling 35,826 shaDecember 18, 2024 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Shares Acquired by Fmr LLCFmr LLC raised its holdings in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 743.1% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 178,957 shares of the medical equipment provider's stDecember 15, 2024 | marketbeat.com Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Email Address AXGN Media Mentions By Week AXGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AXGN News Sentiment▼0.270.71▲Average Medical News Sentiment AXGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AXGN Articles This Week▼253▲AXGN Articles Average Week Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LIVN News TMDX News ENOV News WRBY News NVCR News LMAT News TNDM News SLNO News CNMD News CDRE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AXGN) was last updated on 3/3/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Deep State Surveillance Plot To Sabotage President TrumpThere's a Trump approved IRS-loophole which allows you to steer clear of government overreach and move your re...American Hartford Gold | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredUrgent update to my gold outlookTrump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored3 Undervalued Stocks to Get Today (Revealed)These 3 Stocks Should Do Well Even in a Recession If you’re looking for stocks that offer significant upsid...StockEarnings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AxoGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AxoGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AXGN Stock Alerts